Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis

Patients with cystic fibrosis (CF) who experience acute declines in percent predicted FEV1 (ppFEV1 decreased ≥10% relative to baseline) are often not treated with antibiotics for pulmonary exacerbations (PEx), whereas other patients are treated even when they have not experienced a decline in lung function.

Source: Journal of Cystic Fibrosis - April 20, 2018 Category: Respiratory Medicine Authors: Jeffrey S. Wagener, Michael J. Williams, Stefanie J. Millar, Wayne J. Morgan, David J. Pasta, Michael W. Konstan Tags: Original Article Source Type: research